Covid-19 antiviral pilots

The government announced this month that thousands of the UK’s most vulnerable people will be among the first in the world to access a new antiviral treatment for Covid-19, Molnupiravir. This will take the form of pilot prescribing antivirals to vulnerable people who have caught Covid-19 and a study combining providing antivirals and placebos to healthier people. The Government press release announcing these can be read here.

NHS antiviral prescribing for vulnerable patients

The NHS has confirmed that it will begin offering Molnupiravir from 16 December, to patients who are at the highest risk of becoming seriously ill with coronavirus. Those eligible must be over 12 years old and live with a condition that makes Covid-19 especially dangerous, such as Down’s Syndrome or certain types of cancer. If the NHS considers the antiviral treatment appropriate for an individual, a hospital pharmacy will arrange for the medicine to be delivered to your home. Molnupiravir is administered in capsules to be swallowed.

The full list of eligible patients and more details for the public can be read here. Eligibility closely corresponds to the shielding list criteria used earlier in the pandemic. Further information from the MHRA can be accessed here.

Study of antiviral use in healthy patients

Separately, the University of Oxford, in close collaboration with GP hubs, has launched a national study called PANORAMIC, which will provide 10,000 people with the opportunity to take Molnupiravir at home after testing positive. To participate in the study, individuals must be aged 50 or over or have a pre-existing health condition. 215 participants have currently been recruited across 21 NHS sites across the UK. If eligible, individuals who have tested positive will be contacted by the study team or a local healthcare professional, such as their GP. People can also find out if they meet the requirements at www.panoramictrial.org.

 

 

Last updated : 16 Dec 2021

 

Islington LMC Newsletter - January 2022 (31 Jan 2022)

Please click here to read the latest Islington LMC news update.
Read more »

Tips of the month January 2022 (19 Jan 2022)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

Fuller report response (19 Jan 2022)

Professor Claire Fuller is leading a wide-ranging national stocktake of how best primary care can be supported within the emergent Integrated Care Systems (ICS). The focus of the work will be on...
Read more »

Online and video consultation data collection (19 Jan 2022)

A data provision notice (DPN) for a data collection on Online and Video Consultation in General Practices  was issued to general practices in England on 10 January 2022. NHS...
Read more »

PANORAMIC study (19 Jan 2022)

Dr David Mummery is a member of Hammersmith and Fulham LMC and Clinical Speciality Lead for Primary Care, North West London Clinical Research Network. He writes here about why practice participation...
Read more »

General practice issues in Parliament (19 Jan 2022)

In December, the House of Commons’ Health and Social Care Committee published their report on clearing the backlog caused by the pandemic. Research by the Institute for Fiscal...
Read more »

Managing a remote team module - applications now open (19 Jan 2022)

Runs: online, with a taught day on 4 February 2022 Costs: £325 + VAT This module is suitable for anyone working in a position of management or leadership where members...
Read more »

December 2021 workforce survey results (19 Jan 2022)

Thank you for taking the time to complete our December 2021 workforce survey at time when practice teams were so overstretched. We had 327 responses from 277 individual member practices, of...
Read more »
Next Page »
« Previous Page